Stay updated on SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-09T12:15:07.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry, v3.7.0, was added to the study history. The previous revision v3.6.6 was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-09-18T12:34:35.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' is added to the record history, representing the latest update to the study record's documentation. This updates the history log to reflect the most recent version.
    Difference
    0.1%
    Check dated 2026-08-28T11:47:40.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.5, has been added to the study's record history. The prior revision entry, v3.6.4, has been removed from the list.
    Difference
    0.1%
    Check dated 2026-08-07T10:24:50.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.4) was added to the study history, and the previous revision (v3.6.3) was removed, representing an update to the record version.
    Difference
    0.1%
    Check dated 2026-07-24T12:22:10.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, is added to the study record history. The previous revision, v3.6.2, is removed from the history, updating the version trail for this record.
    Difference
    0.1%
    Check dated 2026-07-03T15:08:06.000Z thumbnail image

Stay in the know with updates to SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.